Correlation Between Talis Biomedical and Cytek Biosciences

Can any of the company-specific risk be diversified away by investing in both Talis Biomedical and Cytek Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Talis Biomedical and Cytek Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Talis Biomedical Corp and Cytek Biosciences, you can compare the effects of market volatilities on Talis Biomedical and Cytek Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Talis Biomedical with a short position of Cytek Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Talis Biomedical and Cytek Biosciences.

Diversification Opportunities for Talis Biomedical and Cytek Biosciences

0.0

Correlation Coefficient

Talis Biomedical  Cytek Biosciences

Pay attention - limited upside

The 3 months correlation between Talis and Cytek is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Talis Biomedical Corp and Cytek Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cytek Biosciences and Talis Biomedical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Talis Biomedical Corp are associated (or correlated) with Cytek Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cytek Biosciences has no effect on the direction of Talis Biomedical i.e., Talis Biomedical and Cytek Biosciences go up and down completely randomly.

Pair Corralation between Talis Biomedical and Cytek Biosciences

If you would invest  380.00  in Cytek Biosciences on May 4, 2025 and sell it today you would lose (16.00) from holding Cytek Biosciences or give up 4.21% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	0.0%
Values	Daily Returns

Talis Biomedical Corp  vs.  Cytek Biosciences

Talis Biomedical Corp

Risk-Adjusted Performance

Very Weak

Over the last 90 days Talis Biomedical Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable forward indicators, Talis Biomedical is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.

Cytek Biosciences

Risk-Adjusted Performance

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Cytek Biosciences are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite somewhat strong forward-looking signals, Cytek Biosciences is not utilizing all of its potentials. The newest stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Talis Biomedical and Cytek Biosciences

The main advantage of trading using opposite Talis Biomedical and Cytek Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Talis Biomedical position performs unexpectedly, Cytek Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cytek Biosciences will offset losses from the drop in Cytek Biosciences' long position.

The idea behind Talis Biomedical Corp and Cytek Biosciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.